𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dutogliptin, a selective DPP4 inhibitor, improves glycaemic control in patients with type 2 diabetes: a 12-week, double-blind, randomized, placebo-controlled, multicentre trial

✍ Scribed by H. M. R. Pattzi; S. Pitale; M. Alpizar; C. Bennett; A. M. O’Farrell; J. Li; J. M. Cherrington; H.-P. Guler; PHX1149-PROT202 Study Group


Book ID
109044952
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
571 KB
Volume
12
Category
Article
ISSN
1462-8902

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES